United States trade sanctions, specifically the Entity List, have driven a 72 per cent surge in science-linked patent applications by targeted Chinese firms. These restricted companies are increasingly turning to open-source scientific literature to reverse-engineer technologies and build internal capabilities. This strategic adaptation now rapidly accelerates technological self-reliance in China.
This shift unfolds against a broader expansion of corporate science within China, where domestic firms are rapidly deepening their integration with academic research. To analyze these strategic shifts, researchers from Shenzhen University, Tsinghua University, and the University of Hong Kong examined Chinese patent filings from 2010 to 2022. Although Chinese firms still lag behind their American counterparts in overall scientific depth, their science-linked patents grew 13.4-fold. Additionally, China leverages its dominance over rare earth mining and processing as a powerful countermeasure to these trade restrictions. Decoupling risks creating two separate, competing global innovation systems. This fragmentation makes knowledge flow highly inefficient.
The expansion of the US Entity List is driving a structural shift in Chinese corporate research and development. By restricting access to proprietary Western technologies, these trade controls force Chinese firms to rely on open-source scientific literature to reverse-engineer critical components. This adaptation is reflected in the rising volume of science-linked patents filed by Chinese entities at the United States Patent and Trademark Office.
Consequently, the growth of independent Chinese standards, particularly in dual-use sectors, will reduce the efficacy of future US export controls. This fragmentation will ultimately diminish the global reach of the United States Patent and Trademark Office as a singular standard-setting body.
No comments:
Post a Comment